All articles by Chris Lo

Chris Lo

Features

AI in healthcare: key highlights in 2021

As AI and machine learning continues to evolve, we look at how it has impacted healthcare in 2021.

Uncategorised

Coronavirus company news summary – UK to start rolling out Merck’s molnupiravir through trial – NRx plans vaccine production facility in Luxembourg

Uncategorised

Coronavirus company news summary – FDA denies EUA to NRx’s Zyesami for critical Covid-19 – AZ will not pursue approval of its Covid-19 vaccine in Switzerland

Uncategorised

Coronavirus company news summary – Lilly to supply more doses of antibody cocktail to US in $1.29bn deal – NRx reports positive safety data in Phase III trial of Covid-19 treatment

Uncategorised

Coronavirus company news summary – Indonesia grants emergency approval to Novavax vaccine – Resverlogix in talks to start Covid-19 treatment trial in Morocco

Uncategorised

Coronavirus company news summary – FDA grants emergency approval to Pfizer/BioNTech shot in children aged 5-11, extends review of Moderna’s jab in adolescents

Features

Global warning: pharma’s role in the climate crisis

With COP26 imminent, what lessons can the pharma sector learn about its environmental impact and its response to climate change?

Uncategorised

Coronavirus company news summary – US buys 50 million Pfizer vaccine doses for paediatric use – ARCA to proceed with Phase IIb trial of severe Covid-19 treatment

Uncategorised

Coronavirus company news summary – CDC committee to discuss Covid-19 vaccines in young children – Merck signs molnupiravir licensing deal with Medicines Patent Pool to increase generic production

Uncategorised

Coronavirus company news summary – FDA panel recommends EUA expansion for Pfizer/BioNTech jab in children aged five to 12 – Vaxart begins world-first Phase II trial of Covid-19 oral tablet vaccine